| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
55,759 |
49,121 |
$2.93M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
62,371 |
57,495 |
$2.16M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,591 |
9,335 |
$350K |
| X5622 |
|
4,659 |
4,364 |
$349K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,807 |
4,681 |
$225K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
10,059 |
9,756 |
$197K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,465 |
4,938 |
$186K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,259 |
3,171 |
$157K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,958 |
2,894 |
$139K |
| 90461 |
|
5,618 |
5,447 |
$116K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,381 |
1,346 |
$70K |
| 99188 |
|
4,625 |
4,549 |
$43K |
| 92551 |
|
5,718 |
5,600 |
$36K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
513 |
491 |
$32K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
374 |
369 |
$30K |
| 99215 |
Prolong outpt/office vis |
350 |
317 |
$28K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,095 |
1,048 |
$24K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,431 |
1,389 |
$23K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,218 |
1,182 |
$21K |
| 96127 |
|
5,264 |
5,188 |
$19K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,985 |
1,803 |
$15K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
135 |
134 |
$14K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
258 |
251 |
$13K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
531 |
512 |
$11K |
| 99173 |
|
5,486 |
5,388 |
$8K |
| 99243 |
|
101 |
99 |
$6K |
| 99443 |
|
138 |
124 |
$5K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
166 |
159 |
$4K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
752 |
637 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
83 |
77 |
$3K |
| 99442 |
|
78 |
74 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
109 |
102 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
74 |
39 |
$3K |
| 99460 |
|
55 |
51 |
$2K |
| 99384 |
|
27 |
27 |
$2K |
| 88141 |
|
56 |
55 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
28 |
26 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$1K |
| 96161 |
|
627 |
601 |
$985.91 |
| 90832 |
Psychotherapy, 30 minutes with patient |
12 |
12 |
$572.88 |
| 77080 |
|
72 |
72 |
$559.83 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
46 |
46 |
$440.40 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
30 |
15 |
$390.22 |
| 99441 |
|
13 |
13 |
$262.73 |
| 90480 |
|
13 |
13 |
$224.62 |
| 90651 |
|
784 |
763 |
$219.44 |
| 90474 |
|
15 |
15 |
$182.56 |
| 36415 |
Collection of venous blood by venipuncture |
58 |
51 |
$96.31 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
14 |
14 |
$36.44 |
| 90633 |
|
1,059 |
998 |
$34.82 |
| 90685 |
|
350 |
335 |
$22.25 |
| 90686 |
|
2,948 |
2,902 |
$4.72 |
| 90670 |
|
2,220 |
2,170 |
$0.30 |
| 90723 |
|
1,539 |
1,502 |
$0.18 |
| 90647 |
|
1,444 |
1,399 |
$0.17 |
| 90680 |
|
1,234 |
1,203 |
$0.12 |
| 90677 |
|
212 |
208 |
$0.10 |
| 90715 |
|
271 |
256 |
$0.00 |
| 90734 |
|
564 |
525 |
$0.00 |
| 90707 |
|
236 |
220 |
$0.00 |
| 90700 |
|
235 |
215 |
$0.00 |
| 90710 |
|
148 |
138 |
$0.00 |
| 17110 |
|
13 |
12 |
$0.00 |
| 90716 |
|
310 |
292 |
$0.00 |
| 90696 |
|
186 |
172 |
$0.00 |
| 90688 |
|
80 |
77 |
$0.00 |
| 90656 |
|
186 |
186 |
$0.00 |